InvestorIntel: David Elsley of Cardiol Therapeutics talks about their global Phase II clinical trials for the treatment of heart diseases

Upcoming Event Cardiol Therapeutics 2023 Annual General Meeting of ShareholdersJun 28, 2023

Past Event FORCE Family Office Webinar – Cardiol Therapeutics: David Elsley, President & CEOApr 11, 2023

Upcoming Event Canaccord Genuity 43rd Annual Growth ConferenceAug 07 - Aug 10, 2023